Sildenafil for women patients with antidepressant-induced sexual dysfunction

Psychiatr Serv. 1999 Aug;50(8):1076-8. doi: 10.1176/ps.50.8.1076.

Abstract

In an open study, sildenafil (Viagra) was prescribed for nine women outpatients who reported sexual dysfunction induced by antidepressant medication, primarily selective serotonin reuptake inhibitors. A 50 mg dose of sildenafil was prescribed, and patients were instructed to take it approximately one hour before sexual activity. They were told to increase the dose to 100 mg on the next occasion if they experienced a partial response or a lack of response to sildenafil. The nine patients, all of whom had experienced either anorgasmia or delayed orgasm with or without associated disturbances, reported significant reversal of sexual dysfunction, usually with the first dose of 50 mg of sildenafil.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Ambulatory Care
  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / therapeutic use
  • Depressive Disorder / drug therapy*
  • Drug Administration Schedule
  • Female
  • Humans
  • Middle Aged
  • Phosphodiesterase Inhibitors / administration & dosage
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Piperazines / administration & dosage
  • Piperazines / therapeutic use*
  • Purines
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Sex Factors
  • Sexual Dysfunctions, Psychological / chemically induced*
  • Sexual Dysfunctions, Psychological / drug therapy*
  • Sildenafil Citrate
  • Sulfones
  • Treatment Outcome

Substances

  • Antidepressive Agents
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Serotonin Uptake Inhibitors
  • Sulfones
  • Sildenafil Citrate